Meropenem Aurobindo

Meropenem, the active ingredient in Meropenem Aurobindo, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, meningitis and septic shock in adult patients.

GNH USA supplies Meropenem Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens. - Complicated urinary tract infections: eradicates resistant Gram‑negative organisms causing severe UTIs. - Hospital‑acquired pneumonia: treats pneumonia caused by multidrug‑resistant bacteria in hospitalized patients. - Ventilator‑associated pneumonia: effective against pathogens associated with ventilator use. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. - Severe sepsis and septic shock: used as part of empirical therapy for life‑threatening systemic infections.

Adverse reactions may occur with meropenem therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional emesis during infusion. - Diarrhea: may be watery or loose. - Headache: transient cranial discomfort. - Infusion site phlebitis: redness or pain at the IV site. - Elevated liver enzymes: transient increase in transaminases. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or high doses. - Anaphylaxis: severe allergic reaction requiring immediate intervention. - Clostridioides difficile‑associated diarrhea: possible colitis. - Thrombocytopenia: reduced platelet count. - Renal impairment: worsening kidney function. - Neutropenia: decreased neutrophil count.

Use meropenem with caution and observe specific safety measures.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy history: avoid in individuals with known carbapenem hypersensitivity. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant. - Concomitant nephrotoxic drugs: monitor renal parameters closely. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Valproic acid: may increase the risk of seizures. - Probenecid: can reduce renal clearance of meropenem, raising plasma levels. - CNS depressants: may potentiate neurotoxic effects.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: assess for additive nephrotoxicity. - Anticoagulants: watch for altered coagulation parameters.